Xerostomia Clinical Trial
Official title:
Coconut Oil as a Novel Approach to Managing Radiation-Induced Xerostomia: An Interventional Study
This study will seek to assess the experience of using of coconut oil as an approach to managing radiation-induced xerostomia in patients previously treated for cancer in the head and neck. There is a high prevalence of radiation-induced xerostomia in this patient population, and the condition has significant negative impact on patients' quality of life. There is currently no agreed-upon standard of care for the treatment of this condition. Anecdotal evidence from patients and both physicians and allied healthcare providers suggests improvement in this condition with the use of coconut oil, but this has not previously been formally studied. We therefore propose a case series study to formally assess the tolerability and efficacy of coconut oil as an approach to managing radiation-induced xerostomia.
Xerostomia, or dry mouth, is a common complication in patients treated with radiotherapy for
cancer of the head and neck, having been cited as occurring to some degree in 60- 100% of
patients. Radiation, either alone or in addition to surgery, is a mainstay in the treatment
of head and neck cancer. The incidence and degree of xerostomia as a side-effect is
proportional to both the dosage of radiation used, and the amount of salivary gland tissue
included in the radiation field. The downstream effects of xerostomia are wide-ranging, and
can include difficulty chewing, swallowing, impaired phonation, altered taste sensation,
dental carries, oropharyngeal candidiasis, systemic malnutrition and weight loss. Several
studies have demonstrated a significant negative impact of xerostomia on patient quality of
life. With cancer of the head and neck being the sixth most commonly diagnosed cancer
worldwide, the burden of xerostomia on both the healthcare system and patient quality of life
should not be underestimated.
There is no single effective treatment for radiation-induced xerostomia. Current treatments
are non-specific, and directed at alleviating symptoms. These include lifestyle modifications
(such as discontinuation of smoking, dairy, and other dietary products that thicken saliva),
artificial saliva preparations, and parasympathetic agents such as pilocarpine which
stimulate saliva production. Artificial saliva preparations such as Biotene© oral lubricant
are commonly used today. However many of these treatments have limited efficacy, are costly,
and the use of pilocarpine in particular is associated with significant side-effects. Other
therapies which have been studied but not definitively proven effective include acupuncture
and hyperbaric oxygen. Submandibular gland transfer, first described in 2000 and subsequently
demonstrated in 2001, has also been shown to be effective in preventing xerostomia, however
is a highly specialized procedure which prolongs the length of surgery, with benefit in only
a limited patient population. Of these potential treatments, certainly Biotene© is the most
common method of alleviating xerostomia. Preliminary evidence in the form of a phase II study
has demonstrated the efficacy of Biotene© in alleviating symptoms of xerostomia in patients
who have undergone radiation for head and neck cancer. The use of Biotene© is common practice
at our tertiary care hospital, The Ottawa Hospital (TOH) although it is not agreed upon as
THE standard of care.
Coconut oil, defined by Health Canada as a natural health / food product, has been
anecdotally suggested to ameliorate the symptoms of xerostomia following radiation treatment
for head and neck cancer. This anecdotal evidence has been derived from discussion with both
patients and healthcare providers at The Ottawa Hospital. Both patients and allied health
care providers involved in the care of patients following radiation treatment for head and
neck cancer have attested to the beneficial effects of coconut oil. However, the effects of
coconut oil in the management of radiation-induced xerostomia in patients previously treated
for cancer of the head and neck have not been formally studied.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05342272 -
Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction
|
Phase 3 | |
Completed |
NCT03302676 -
The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors
|
N/A | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Completed |
NCT01272570 -
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
|
N/A | |
Completed |
NCT00656513 -
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00911768 -
Effect of Korean Red Ginseng (KRG) on Dry Mouth
|
Phase 4 | |
Completed |
NCT00332618 -
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
|
Phase 2 | |
Completed |
NCT03494985 -
A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water
|
N/A | |
Completed |
NCT05058430 -
SaliPen Human Factors Study for OTC Labeling
|
N/A | |
Recruiting |
NCT02705937 -
Early Phase Study Comparing the Effectiveness of a Dairy Product With the Reference Treatment Aequasyal® on Dry Mouth Symptoms in Patients Suffering From Xerostomia Caused by Psychotropic Medications.
|
N/A | |
Completed |
NCT05247008 -
Effectiveness of Thyme Honey in Management of Xerostomia in ESRD
|
N/A | |
Recruiting |
NCT03632096 -
Photobiomodulation in Salivary Production of Patients With Xerostomy
|
Phase 2 | |
Not yet recruiting |
NCT04323384 -
The Effect of Biotene® on the Symptoms of Xerostomia and Mastication and Swallowing
|
N/A | |
Not yet recruiting |
NCT03530735 -
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
|
N/A | |
Enrolling by invitation |
NCT06122636 -
Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC
|
N/A | |
Completed |
NCT03611283 -
Topical Management of Xerostomia With Dry Mouth Products
|
N/A | |
Completed |
NCT02682199 -
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
|
||
Withdrawn |
NCT01960101 -
Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Medication
|
N/A | |
Completed |
NCT02317172 -
Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases
|
N/A | |
Completed |
NCT00350350 -
OGT Spray in the Management of Xerostomia in the Elderly
|
Phase 3 |